Vigilance in Tackling Drug Resistance in the Global Battle Against HIV
This is the third in a series of blog posts exploring the threat that drug resistance poses in fighting the...
Robust malaria investments see returns and keep progress from sliding backwards
Malaria has been in the news recently with reports shining a spotlight on the dangers of drug-resistant strains of the...
Friends Welcomes former Sen. Bill Frist and Dr. Eric Goosby to Board of Directors
WASHINGTON, D.C.—Friends of the Global Fight Against AIDS, Tuberculosis and Malaria (Friends) is very pleased to welcome two new members...
US can’t be the only one to shoulder the financial responsibility of AIDS
The following post was originally published at The Hill on Nov. 29, 2017. This Dec. 1 marks the 15th World AIDS...
How the Global Fund Is Responding to Resistance Threats in Malaria Control
This is the second in a series of blog posts exploring the threat that drug resistance poses in fighting the...
How Investments in Global Health Promote U.S. Security
The U.S. government recognizes that its health system is not insulated from the rest of the world, recently taking the...
Key Takeaways: The Global Fund’s 38th Board Meeting
The following are some key takeaways from the Global Fund’s 38th Board Meeting, held on November 14-15, in Geneva. 1....
Friends Welcomes Peter Sands as New Executive Director of the Global Fund
FOR IMMEDIATE RELEASE Washington, D.C.—Friends of the Global Fight Against AIDS, Tuberculosis and Malaria (Friends) welcomes today’s decision by the...
Opinion: How fighting diseases globally makes everyone safer
The following post was originally published at Devex on Oct. 30, 2017. In our increasingly interconnected world, people, products, and...
Leveraging Development Finance Institutions for Better Health
An expert panel met recently at the Center for Strategic and International Studies to discuss the value of Development Finance...
Experts highlight goals and innovations to help end the TB epidemic by 2030
Now the leading infectious disease killer, tuberculosis (TB) is in the global spotlight as world health leaders prepare for next...
Getting serious about financing the end of epidemics
The following post was originally published at the Lancet Global Health Blog on Oct. 6, 2017. The U.S. Congress appears...